The Angina (Angina Pectoris) drugs in development market research report provides comprehensive information on the therapeutics under development for Angina (Angina Pectoris), complete with analysis ...

and/or refractory angina with respect to 'real-life' drug side effects and toxicity, therapeutic drug level monitoring, 5 year mortality outcomes and predictors of response to perhexiline therapy.

Cardiac Syndrome X, or microvascular angina, is diagnosed when a person has angina, with evidence of cardiac ischemia on stress testing, but with normal-looking coronary arteries on cardiac ...

The first drug level check was performed on average ... For patients with CHF, refractory angina, or both, the mean dosages were 194 ± 98, 179 ± 72, and 236 ± 90 mg/day, respectively (P ...

Short-acting sublingual (under the tongue) nitroglycerine is currently recommended for all people as the best first-line treatment for immediate relief of acute angina symptoms. Long-acting nitrates ...

Tenormin (atenolol) is a brand-name oral tablet that’s prescribed for high blood pressure, angina, and heart attack in adults. As with other drugs ... It’s also best to avoid drinking alcohol ...

From using his home in beautiful Bend, OR as a testing zone for the latest security products to digging into the nuts and bolts of the best data privacy guidelines, Tyler has experience in all ...

or gotten a diagnosis of CAD or angina. But those with scores between 7.5% and 20% also should get help reducing the risk factors that affect their score, which often includes medication.

Merck & Co’s immuno-oncology drug Keytruda (pembrolizumab) is projected to be the best-selling drug by annual revenue in 2023, earning $22.2 billion by 2025, according to new research by GlobalData.

The goal was to find out which combination worked best for managing blood sugar levels over time. The study included 5,047 participants, all of whom were already using metformin.